Lana Medical posts 45% profit decline to SAR 3M in 2023

Lana Medical posts 45% profit decline to SAR 3M in 2023

31/03/2024 Argaam Exclusive

View other reports

Lana Medical Co. reported a net profit of SAR 3 million in 2023, a slump of 45% from SAR 5.5 million a year earlier.



Financials (M)

Item 2022 2023 Change‬
Revenues 40.80 48.63 19.2 %
Gross Income 18.87 20.14 6.7 %
Operating Income 6.56 4.57 (30.4 %)
Net Income 5.49 3.01 (45.2 %)
Average Shares 3.00 3.60 20.0 %
EPS (Riyals) 1.83 0.84 (54.3 %)


Current Half Annual Comparison (M)

Compared With The
Item H2 2022 H2 2023 Change‬

The annual profit decline was attributed to recording expenses related to the company’s Nomu listing, which took place on Dec. 6, 2023, and the pre-operating expenses related to the waste treatment plant in Jeddah and the hazardous medical waste treatment plant in Hail.

 

This came despite the 19.2% year-on-year (YoY) increase in net revenues due to the company’s expansion of its market share, with the awarding of government projects also playing a pivotal role in boosting sales.
 

Total shareholders’ equity, no minority interest, advanced to SAR 68.05 million by Dec. 31, 2023, compared to SAR 47.42 million a year ago.



Financial results (Million)

Period Revenues Change Gross Income Change Operating Income Change
H1 2014 - - - - - -
H2 2014 - - - - - -
H1 2015 - - - - - -
H2 2015 - - - - - -
H1 2016 - - - - - -
H2 2016 - - - - - -
H1 2017 - - - - - -
H2 2017 - - - - - -
H1 2018 - - - - - -
H2 2018 - - - - - -
H1 2019 - - - - - -
H2 2019 - - - - - -
H1 2020 - - - - - -
H2 2020 - - - - - -
H1 2021 - - - - - -
H2 2021 - - - - - -
H1 2022 - - - - - -
H2 2022 - - - - - -
H1 2023 21.67 - 8.09 - 3.84 -
H2 2023 26.96 - 12.06 - 0.73 -
2023 48.63 19.2 % 20.14 6.7 % 4.57 (30.4 %)


Profit Performance (Million)

Period Net Income Change EPS(Riyal) Extraordinary Income/Expense Net Profit Before Unusual Items EPS Before XO Items
H1 2014 - - - - - -
H2 2014 - - - - - -
H1 2015 - - - - - -
H2 2015 - - - - - -
H1 2016 - - - - - -
H2 2016 - - - - - -
H1 2017 - - - - - -
H2 2017 - - - - - -
H1 2018 - - - - - -
H2 2018 - - - - - -
H1 2019 - - - - - -
H2 2019 - - - - - -
H1 2020 - - - - - -
H2 2020 - - - - - -
H1 2021 - - - - - -
H2 2021 - - - - - -
H1 2022 - - - - - -
H2 2022 - - - - - -
H1 2023 3.06 - 1.02 - 3.06 1.02
H2 2023 (0.05) - (0.01) - (0.05) (0.01)
2023 3.01 (45.2 %) 0.84 - 3.01 0.84

Profitability

Period Gross Margin OIBDA Margin Net Margin Before Unusual Items
H1 2014 - - -
H2 2014 - - -
H1 2015 - - -
H2 2015 - - -
H1 2016 - - -
H2 2016 - - -
H1 2017 - - -
H2 2017 - - -
H1 2018 - - -
H2 2018 - - -
H1 2019 - - -
H2 2019 - - -
H1 2020 - - -
H2 2020 - - -
H1 2021 - - -
H2 2021 - - -
H1 2022 - - -
H2 2022 - - -
H1 2023 - - -
H2 2023 41.42 % 13.18 % 6.19 %
2023 41.42 % 13.18 % 6.19 %


Per Share Data (Riyal)

Compared With The
Period Shares Outstanding (M) EPS (Riyal) Adjusted EPS (Riyal) Book Value (BV)
H1 2014 - - - -
H2 2014 - - - -
H1 2015 - - - -
H2 2015 - - - -
H1 2016 - - - -
H2 2016 - - - -
H1 2017 - - - -
H2 2017 - - - -
H1 2018 - - - -
H2 2018 - - - -
H1 2019 - - - -
H2 2019 - - - -
H1 2020 - - - -
H2 2020 - - - -
H1 2021 - - - -
H2 2021 - - - -
H1 2022 - - - -
H2 2022 - - - -
H1 2023 3.00 - - 16.83
H2 2023 3.60 0.84 0.84 18.90

Multiple Ratios (End of Period Price)

Compared With The
Period P/E Adjusted P/E Price/book
H1 2014 - - -
H2 2014 - - -
H1 2015 - - -
H2 2015 - - -
H1 2016 - - -
H2 2016 - - -
H1 2017 - - -
H2 2017 - - -
H1 2018 - - -
H2 2018 - - -
H1 2019 - - -
H2 2019 - - -
H1 2020 - - -
H2 2020 - - -
H1 2021 - - -
H2 2021 - - -
H1 2022 - - -
H2 2022 - - -
H1 2023 - - -
H2 2023 38.28 38.28 1.69

Business Segments (Million)

Compared With The
Period Medical waste treatment Medical supplies Medical devices Contracting
Q2 2023 10.89 5.50 5.28 -
Q4 2023 9.62 6.55 7.08 3.71

Current
Market Cap (M Riyal) 132.12
Enterprise Value (EV) (M) 118.88
Shares Outstanding ((M)) 3.60
Book Value (BV) ( Riyal) 18.90
Par Value ( Riyal) 10.00
Adjusted P/E (Last12) 43.90
Price/book 1.94

Share Price

36.70
1.20 3.38 %

Lana Medical Co. (LANA)


Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.